Blanket Purchase Agreement 36F79721D0019-36C24823A0010
Award Date
2/8/23
Last Date to Order
1/31/28
Federal Agency
Veterans Integrated Service Network 8
Awardee
Veracyte Labs SD Corporation
Ultimate Awardee
Veracyte, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the provision of Decipher Prostate Cancer Testing services. This contract, valued at up to $991,815.95, is established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not have a set-aside designation. The contract aims to support the VA's efforts to provide personalized,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a single-award Blanket Purchase Agreement to Decipher Biosciences, Inc., operating under Veracyte Labs SD Corp, against the Medical Laboratory Testing and Analysis Services schedule. The BPA call provides for prostate testing services in the amount of $390,000 to be performed over an 11-month period in San Diego, California. Specifically, the contractor will deliver Decipher Prostate...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery, indefinite quantity contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., with a potential value of $249,000.00 and a period of performance through September 30, 2023. Against this contract, the agency issued four firm fixed price delivery orders for prostate cancer testing services. The orders called for providing the proprietary...
The key products and services being delivered under this federal contract IDV award are specialized genomic testing services, primarily focused on prostate cancer diagnostics and treatment planning. The prime contractor, Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., provides its proprietary Decipher Prostate Cancer Test and other advanced molecular diagnostic capabilities to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Networks (VISNs)...
The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
This indefinite delivery contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, has a ceiling value of $2,000,000 and an ultimate completion date of April 30, 2028. Under this contract, Veracyte will provide reference laboratory services, including specialized genomic testing and classifier services, to support...
The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 22 awarded a single-award Blanket Purchase Agreement (BPA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype genetic testing services. The BPA has a ceiling value of $970,352 and a period of performance from February 2023 through February 2028. Under this IDV, the VA can order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis at...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 1 to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. The single-award BPA, valued at $1,352,736, will provide the VA's VISN 1 facilities with an estimated 1,800 ExoDx Prostate (IntelliScore) tests over a five-year period. The ExoDx Prostate test is a non-invasive, urine-based liquid biopsy that analyzes exosomal RNA biomarkers to assess...